glp 1 drugs and alzheimer's 🧐Will GLP-1RA be the future of altzeimers treatement? 🧠There are multiple studies underway assessing the effectiveness of glp-1 class of medications in prevention and/or delay of dementia 🧠Alzheimer's makes up 60%-80% CKD Dementia Risk Reduced with

Individuals already taking GLP-1 receptor agonists for diabetes or weight management should continue their prescribed therapy as directed, but should not expect guaranteed cognitive benefits beyond those associated with improved metabolic health

American journal of perinatology , 26 (1), 8188 3

Beyond diabetes and weight loss GLP-1 drugs have exploded in use in recent years for diabetes and weight loss, and they have shown benefits for a wide range of other health conditions, such as protecting the heart and kidneys, reducing sleep apnea and potentially helping with addiction

However, Eli Lilly launched its own weight loss pill, orforglipron, marketed as Foundayo, in April

Liraglutide Regulates Mitochondrial Quality Control System Through PGC-1alpha in a Mouse Model of Parkinsons Disease

GLP-1R KO can lead to increased appetite, contributing to weight gain